| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 54.985 | 35.226 | 69.013 | 81.213 | 90.975 | 74.581 | 74.884 | 109.874 | 114.286 | 128.830 |
| Total Income - EUR | 77.031 | 49.126 | 90.706 | 105.245 | 119.317 | 96.432 | 99.817 | 157.101 | 157.053 | 174.292 |
| Total Expenses - EUR | 73.352 | 47.811 | 96.332 | 97.037 | 111.146 | 105.891 | 111.046 | 160.850 | 150.593 | 165.913 |
| Gross Profit/Loss - EUR | 3.680 | 1.315 | -5.626 | 8.208 | 8.171 | -9.459 | -11.229 | -3.749 | 6.461 | 8.379 |
| Net Profit/Loss - EUR | 2.030 | 963 | -6.316 | 7.388 | 7.261 | -10.149 | -11.978 | -4.644 | 5.318 | 5.050 |
| Employees | 6 | 8 | 8 | 7 | 6 | 6 | 7 | 6 | 7 | 8 |
Check the financial reports for the company - Tenarzol S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.683 | 2.824 | 1.969 | 1.089 | 1.054 | 1.034 | 1.011 | 1.014 | 1.011 | 1.005 |
| Current Assets | 5.662 | 8.761 | 6.648 | 11.763 | 18.617 | 8.793 | 3.813 | 13.365 | 12.920 | 19.575 |
| Inventories | 1.431 | 4.939 | 4.109 | 8.083 | 14.009 | 6.402 | 2.292 | 8.600 | 10.825 | 8.097 |
| Receivables | 505 | 827 | 288 | 2.093 | 1.972 | 164 | 855 | 1.100 | 1.036 | 8.852 |
| Cash | 3.725 | 2.996 | 2.251 | 1.588 | 2.636 | 2.227 | 666 | 3.665 | 1.059 | 2.627 |
| Shareholders Funds | 4.834 | 5.748 | -666 | 6.735 | 13.865 | 3.453 | -8.601 | -13.271 | -7.913 | -2.819 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.511 | 5.838 | 9.283 | 6.117 | 5.805 | 6.373 | 13.425 | 27.650 | 22.379 | 24.161 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1061 - 1061" | |||||||||
| CAEN Financial Year |
1061
|
|||||||||
Comments - Tenarzol S.r.l.